Experience with BFM 1990 Protocol Treatment of Recurrent Childhood Lymphoblastic Leukemia. Report of the Polish Children’s Leukemia/Lymphoma Study Group

  • J. Bogusławska-Jaworska
  • A. Chybicka
  • W. Wojciechowska
  • E. Gorczyńska
  • J. Armata
  • W. Balwierz
  • H. Bubała
  • B. Filiks-Litwin
  • P. Kołecki
  • J. Kowalczyk
  • K. Łukowska
  • M. Matysiak
  • R. Rokicka-Milewska
  • D. Sońta-Jakimczyk
  • W. Strojny
  • M. Wieczorek
  • E. Zelenay
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 39)

Abstract

Between 1993 and 1996,54 children aged from 6 mths-18 years (16 girls and 38 boys) with first relapse of acute lymphoblastic leukemia were included to the study. The children were treated according to the BFM 90 relapse protocol. There were 40 cases with early (including 14 children with very early) and 14 cases with late relapse (BM-30, local-12, combined 12). The probability of EFS were calculated according to the Kaplan-Meier method.

The overall second complete remission (CR) rate in very early was 71.42%, in early relapse was 73.07% and in late relapse 78.57%. The probability of overall event-free survival (EFS) after 2 years was 39.9%. The EFS achieved in children with late relapses was four times higher when compared with early and very early relapses 73.2% vs. 59% vs.29.2% (p = 0.05).

The results obtained with BFM 90 chemotherapy in children with first late relapse are acceptable. One must conclude that for children with early relapses, other chemotherapy methods together with BMT in second remission should be applied.

Keywords

Toxicity Lymphoma Leukemia Oncol Dexamethasone 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brisco MJ, Condon J, Hughes E, Neoh SH, Sykes PJ, Seshadri R, Toogood I, Waters K, Tauro G, Ekert H, Morley AA (1994) Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction. Lancet 343: 196–199PubMedCrossRefGoogle Scholar
  2. 2.
    Falleta JM, Schuster JJ, Grist WM, Pullen J, Bortowitz MJ, Wharam M, Patterson R, Foreman E, Vietti TJ (1992). Different patterns of relapse associated with three intensive treatment regiments for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Study Group. Leukemia 6: 541–546Google Scholar
  3. 3.
    Belasco JB, Luery N, Scher Ch (1990) Multiagent chemotherapy in relapsed acute lymphoblastic leukemia in children. Cancer 66: 2492–2497PubMedCrossRefGoogle Scholar
  4. 4.
    Culbert J, Schuster J, Land VJ, Wharam D, Thomas RM, Nitschke R, Pinkel D, Vietti T (1991) Remission induction and continuation therapy in children with their first relapse of acute lymphoblastic leukemia. Cancer 67: 37–42PubMedCrossRefGoogle Scholar
  5. 5.
    Pui Ch, Bowman P, Ochs J, Dodge RK, Riviera G (1988) Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy. Med Ped Oncol 16: 21–26CrossRefGoogle Scholar
  6. 6.
    Riehm H (1986) Treatment protocol ALL BFM-83. Klin Pediatr 199: 151–160CrossRefGoogle Scholar
  7. 7.
    Riviera GK, Santana V, Mahmoud H, Buchanan G, Crist WM (1989) Acute lymphoblastic leukemia of childhood: the problem of relapses. BMT 4: 80–85Google Scholar
  8. 8.
    Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observations. J Am Stat 53: 457–466CrossRefGoogle Scholar
  9. 9.
    Conter V, Arico M, Valsecchi MG et al. (1995) Extended intrathecal methotrexate mat replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with BerlinMunster-based intensive chemotherapy. J Clin Oncol 13/10: (2497–2502)PubMedGoogle Scholar
  10. 10.
    Boguslawska-Jaworska J, Chybicka A, Kazanowska B, Pietras W, Armata J, Balwierz W, Bubala H, Jackowska T, Koehler T, Michalewska D, Ochocka M, Radwanska U, Rokicka-Milewska R, Rytlewska M, Skomra S, Sladkowska G, Zelenay E (1990) The results of ALL relapses treatment according to BFM protocol in experience of the Polish children’s leukemia/lymphoma study group. Prac Nauk AM: Suppl 88–95Google Scholar
  11. 11.
    Sauerbrey A, Zintl F, Malke H, Reimann M, Maaser M, Domula M, Dorffel W, Eggers G, Exadaktylos P, Kotte W (1993) Results and experiences with a modified BFM protocol for treatment of recurrence in children with acute lymphoblastic leukemia in East German areas. Klin PNdiatr 205: 281–287, Cancer 73: 219–223Google Scholar
  12. 12.
    Behrendt H, Leeuven E, Schurwirth C, Verkes R, Hermans J, Does van der Berg,Wering ER (1990) Bone marrow relapse occurring as first relapse in children with acute lymphoblastic leukemia. Med Oed Oncol 18: 190–196Google Scholar
  13. 13.
    Borgmann A, Schmid H, Hartmann R et al. (1995) Autologous bone marrow transplants compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: A matched-pair analysis. Lancet 346/8979: (873–876)PubMedCrossRefGoogle Scholar
  14. 14.
    Steinhertz P (1989) Reinduction therapy for advanced or refractory acute lymphoblastic leukemia of childhood. Cancer 63: 1472–1476CrossRefGoogle Scholar
  15. 15.
    Kühl JS, Krajewski S, Duran GE, Reed JC, Sikic BI (1997) Spontaneous overexpression, of the long form of the Bd-X protein in a highly resistant P388 leukaemia. Brit J Cancer 75 (2): 268–274PubMedCrossRefGoogle Scholar
  16. 16.
    Schroeder H, Grawicz S, Kristinsson J et al. (1995) Outcome after first relapse in children with acute lymphoblastic leukemia: A population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO). Med Pediat Oncol 25/5: (372–378)CrossRefGoogle Scholar
  17. 17.
    Henze G (1991) 6-year experience with comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALLREZ BFM 85). A relapse study of BFM Group. Blood 78: 1166–1292PubMedGoogle Scholar
  18. 18.
    Alarcon PA, Trigg ME, Giller ME, Rumelhardt Holida M, Wen B (1990) Bone marrow transplantation improves survival for children with acute lymphoblastic leukemia in relapse. Am J Ped Hematol/Oncol 12: 468–471CrossRefGoogle Scholar
  19. 19.
    Buchanan GP, Riviera GK, Boyett JM, Chauvent AR, Crist WM, Vietti TJ (1988) Reinduction therapy in 297 children with acute lymphoblastic leukemia in first bone marrow relapse: a Pediatric Oncology Group Study. Blood 72: 1286–1292PubMedGoogle Scholar
  20. 20.
    Butturini A (1987) Which treatment for childhood acute lymphoblastic leukemia in second remission? Lancet: 429–432Google Scholar
  21. 21.
    Finkelstein J, Miller D, Feusner J, Stram D, Baum E, Shina D, Johnson D, Gyepes M, Hammond D (1994) Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic leukemia. Cancer 73: 219–223CrossRefGoogle Scholar
  22. 22.
    Gale RP, Simone JV, Hoelzer D, Frei E (1991) Curing leukemia. Leukemia 5: 632–635PubMedGoogle Scholar
  23. 23.
    Uderzo C, Zurlo MG, Adamoli L, Zanesco L, Calculi A, Comelli A, Montemezemolo L, Di Tulio M, Guazelli C, Donfrancesco A, Werner B (1990) Treatment of isolated testicular relapse in childhood acute lymphoblastic leukemia: An Italian Multicenter Study. J Clin Oncol 8: 672–677PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • J. Bogusławska-Jaworska
    • 1
  • A. Chybicka
    • 1
  • W. Wojciechowska
    • 1
  • E. Gorczyńska
    • 1
  • J. Armata
    • 2
  • W. Balwierz
    • 2
  • H. Bubała
    • 7
  • B. Filiks-Litwin
    • 3
  • P. Kołecki
    • 4
  • J. Kowalczyk
    • 3
  • K. Łukowska
    • 6
  • M. Matysiak
    • 5
  • R. Rokicka-Milewska
    • 6
  • D. Sońta-Jakimczyk
    • 7
  • W. Strojny
    • 2
  • M. Wieczorek
    • 7
  • E. Zelenay
    • 5
  1. 1.Department Children’s HematologyPolish American Children’s Hospital M. Copernicus Institute of PediatricsKrakowPoland
  2. 2.Department Children’s HematologyInstitute of Pediatrics, Faculty of MedicineLublinPoland
  3. 3.Department Children’s Hematology and OncologyFaculty of MedicinePoznanPoland
  4. 4.Department Children’s Hematology and OncologyFaculty of MedicineWarsawPoland
  5. 5.Department Children’s HematologyFaculty of MedicineWarsawPoland
  6. 6.Department Children’s Hematology and OncologyFaculty of MedicineZabrzePoland
  7. 7.Department Children’s Hematology and OncologyFaculty of MedicineWroclawPoland

Personalised recommendations